NL191508C - Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. - Google Patents

Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.

Info

Publication number
NL191508C
NL191508C NL8001721A NL8001721A NL191508C NL 191508 C NL191508 C NL 191508C NL 8001721 A NL8001721 A NL 8001721A NL 8001721 A NL8001721 A NL 8001721A NL 191508 C NL191508 C NL 191508C
Authority
NL
Netherlands
Prior art keywords
glycinamide derivative
preparation
glycinamide
pharmaceutical preparation
preparation containing
Prior art date
Application number
NL8001721A
Other languages
English (en)
Dutch (nl)
Other versions
NL191508B (nl
NL8001721A (nl
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NL8001721A publication Critical patent/NL8001721A/nl
Publication of NL191508B publication Critical patent/NL191508B/xx
Application granted granted Critical
Publication of NL191508C publication Critical patent/NL191508C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8001721A 1979-03-22 1980-03-24 Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. NL191508C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive
LU81068 1979-03-22
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives
LU81069 1979-03-22

Publications (3)

Publication Number Publication Date
NL8001721A NL8001721A (nl) 1980-09-24
NL191508B NL191508B (nl) 1995-04-18
NL191508C true NL191508C (nl) 1995-08-21

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8001721A NL191508C (nl) 1979-03-22 1980-03-24 Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.

Country Status (18)

Country Link
US (1) US4639468A (en, 2012)
AT (1) AT381302B (en, 2012)
AU (1) AU536499B2 (en, 2012)
CA (1) CA1184567A (en, 2012)
CH (1) CH645091A5 (en, 2012)
DE (2) DE3050800C2 (en, 2012)
DK (1) DK162714C (en, 2012)
ES (1) ES490536A0 (en, 2012)
FI (1) FI82033C (en, 2012)
FR (1) FR2451913A1 (en, 2012)
GB (1) GB2048852B (en, 2012)
GR (1) GR68005B (en, 2012)
IE (1) IE49751B1 (en, 2012)
IL (1) IL59679A (en, 2012)
NL (1) NL191508C (en, 2012)
NO (1) NO157817C (en, 2012)
PT (1) PT70992A (en, 2012)
SE (1) SE453917B (en, 2012)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
FI832935A7 (fi) * 1982-08-20 1984-02-21 Midit Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
HUP0100815A3 (en) * 1996-05-31 2002-11-28 Allelix Neuroscience Inc South Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
BR9909103A (pt) * 1998-03-26 2001-10-16 Univ Saskatchewan ácidos alifático amino carboxìlico e amino fosfÈnico, amino nitrilas e amino tetrazóis como agentes de resgate celular
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
WO2000046183A1 (en) * 1999-02-08 2000-08-10 Checkpoint Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
CA2416821A1 (en) 2000-07-21 2002-01-31 Teva Pharmaceutical Industries, Ltd. Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
DK1311256T3 (da) * 2000-08-17 2005-11-28 Teva Pharma Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser
WO2002042256A2 (en) * 2000-11-21 2002-05-30 Ucb, S.A. N-alkylated gaba compounds, processes for their preparation and their use as medicaments
JP2004523548A (ja) 2001-02-16 2004-08-05 アレリックス ニューロサイエンス インコーポレーテッド ＧｌｙＴ−１阻害剤
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
AU2002333374B2 (en) 2001-09-03 2007-03-22 Newron Pharmaceuticals S.P.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
MX2007002713A (es) * 2004-09-10 2007-05-23 Newron Pharm Spa Uso de las (halobenciloxi) bencilamino-propanamidas para la fabricacion de medicamentos activos como moduladores selectivos de los canales de sodio y/o calcio.
EP1791932A1 (en) * 2004-09-13 2007-06-06 Ciba Specialty Chemicals Holding Inc. Alkylaminoacetamide lubricant additives
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学（阜新）技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
EP4148083A1 (en) 2014-06-25 2023-03-15 Acuitas Therapeutics Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
IL283545B2 (en) 2015-06-29 2023-09-01 Acuitas Therapeutics Inc Lipids and nanoparticulate lipid formulations for delivery of nucleic acids
PL3368507T3 (pl) 2015-10-28 2023-03-27 Acuitas Therapeutics Inc. Nowe preparaty lipidów i nanocząstek lipidowych do dostarczania kwasów nukleinowych
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
US11820728B2 (en) 2017-04-28 2023-11-21 Acuitas Therapeutics, Inc. Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
ES2997124T3 (en) * 2017-08-17 2025-02-14 Acuitas Therapeutics Inc Lipids for use in lipid nanoparticle formulations
WO2020061426A2 (en) 2018-09-21 2020-03-26 Acuitas Therapeutics, Inc. Systems and methods for manufacturing lipid nanoparticles and liposomes
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
SG11202106987WA (en) 2019-01-11 2021-07-29 Acuitas Therapeutics Inc Lipids for lipid nanoparticle delivery of active agents
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
EP4182297A1 (en) 2020-07-16 2023-05-24 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles
US12129223B2 (en) 2021-12-16 2024-10-29 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
LU43649A1 (en, 2012) * 1962-05-09 1963-07-16
JPS5319654B2 (en, 2012) 1974-03-14 1978-06-22
DE2832009A1 (de) 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
IE49751B1 (en) 1985-12-11
IL59679A (en) 1984-11-30
FI82033C (fi) 1991-01-10
FI800900A7 (fi) 1980-09-23
FR2451913B1 (en, 2012) 1984-07-13
IE800599L (en) 1980-09-22
ES8104790A1 (es) 1981-04-16
NO800830L (no) 1980-09-23
NL191508B (nl) 1995-04-18
DE3050800C2 (en, 2012) 1989-06-22
IL59679A0 (en) 1980-06-30
AU536499B2 (en) 1984-05-10
FR2451913A1 (fr) 1980-10-17
ES490536A0 (es) 1981-04-16
DK123580A (da) 1980-09-23
GB2048852B (en) 1983-03-30
NO157817C (no) 1988-05-25
CH645091A5 (fr) 1984-09-14
DK162714B (da) 1991-12-02
DE3010599C2 (en, 2012) 1989-03-02
DE3010599A1 (de) 1980-10-09
AU5678480A (en) 1980-09-25
NL8001721A (nl) 1980-09-24
DK162714C (da) 1992-04-21
AT381302B (de) 1986-09-25
ATA154680A (de) 1986-02-15
NO157817B (no) 1988-02-15
FI82033B (fi) 1990-09-28
PT70992A (fr) 1980-04-01
US4639468A (en) 1987-01-27
SE8002204L (sv) 1980-09-23
GR68005B (en, 2012) 1981-10-26
GB2048852A (en) 1980-12-17
CA1184567A (en) 1985-03-26
SE453917B (sv) 1988-03-14

Similar Documents

Publication Publication Date Title
NL191508C (nl) Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.
NO801863L (no) Farmasoeytiske preparater.
FI803935A7 (fi) Syklo-oktapeptidit ja niitä sisältävät farmaseuttiset valmisteet, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI802079A7 (fi) Uudet syklopeptidit ja niistä tehdyt farmaseuttiset valmisteet, sekä menetelmä niiden valmistamiseksi.
NL190237C (nl) Amino-ethers en geneesmiddel dat deze amino-ethers bevat.
FI820178A7 (fi) Fosforyyliyhdisteet, menetelmä niiden valmistamiseksi, näitä yhdisteitä sisältävät farmaseuttiset valmisteetja niiden käyttö.
NL189041C (nl) Werkwijze ter bereiding van optisch aktieve azabicyclohexanen alsmede werkwijze ter bereiding van een farmaceutisch preparaat.
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
FI803202A7 (fi) Fosfonohydroksietikkahappo, sen valmistusmenetelmä sekä käyttö lääkeaineena.
NL187239C (nl) N-gesubstitueerd 2-cyaanaziridinederivaat, werkwijze voor het bereiden daarvan en farmaceutisch preparaat dat een dergelijk preparaat bevat.
FI814175A7 (fi) Tiatsoliinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuperustuvia farmaseuttisia valmisteita.
NL7802380A (nl) Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7714628A (nl) Gedisubstitueerde piperazinen, werkwijze voor de bereiding daarvan en dergelijke piperazinen bevattende geneesmiddelen.
FI802107A7 (fi) Aminotiadiatsolyyliyhdisteet, menetelmä niiden valmistamiseksi, niitä sisältävät farmaseuttiset valmisteet ja niiden käyttö.
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
DZ276A1 (fr) Préparations pharmaceutiques.
NL7902268A (nl) 2-hydroxymethylpyrazine-derivaten en een werkwijze voor de bereiding daarvan.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NL177214C (nl) Geneeskrachtige preparaten met antimycotische eigenschappen, die 2,4-dichloorfenylimidazolylverbindingen bevatten, alsmede geneeskrachtige verbindingen geschikt voor gebruik in deze preparaten.
NL182641C (nl) 3-amino-5-(4-pyridyl)-1,2,4-triazoolderivaten en deze derivaten bevattende farmaceutische preparaten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: CONTINENTAL PHARMA, INC.

BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20000324